We read with great interest the article by Lazo and colleagues and the accompanying editorial. The study concludes that there is no association between ultrasound-diagnosed nonalcoholic fatty liver (NAFLD) with/without elevated serum liver enzymes and deaths from all causes, cardiovascular disease (CVD), cancer, or liver diseases in a large population-based sample of United States adults during a median follow-up of 14.5 years; the editorial correctly identifies a few limits of the study which are potentially responsible for these unexpected and surprising findings, conflicting with most of the literature data.
NAFLD and adverse hepatic and extra-hepatic outcomes / G. Targher; M.B. Chonchol; G. Marchesini Reggiani. - In: BMJ. BRITISH MEDICAL JOURNAL. - ISSN 0959-8138. - STAMPA. - 343:(2011), pp. d6891-d6891. [10.1136/bmj.d6891]
NAFLD and adverse hepatic and extra-hepatic outcomes
MARCHESINI REGGIANI, GIULIO
2011
Abstract
We read with great interest the article by Lazo and colleagues and the accompanying editorial. The study concludes that there is no association between ultrasound-diagnosed nonalcoholic fatty liver (NAFLD) with/without elevated serum liver enzymes and deaths from all causes, cardiovascular disease (CVD), cancer, or liver diseases in a large population-based sample of United States adults during a median follow-up of 14.5 years; the editorial correctly identifies a few limits of the study which are potentially responsible for these unexpected and surprising findings, conflicting with most of the literature data.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
